Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Lincoff

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Circulation|October 7, 1997
Does stenting prevent diabetic arterial shrinkage after percutaneous coronary revascularization?A M Lincoff
American Heart Journal|January 29, 2000
Potent complementary clinical benefit of abciximab and stenting during percutaneous coronary revascularization in patients with diabetes mellitus: results of the EPISTENT trialA M Lincoff
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 18, 2001
Anticoagulant and antiplatelet drugsA M Lincoff
The Journal of Invasive Cardiology|December 9, 1993
Patients at high risk for ischemic complicationsA M Lincoff
JAMA|October 12, 2000
Stent scrutinyA M Lincoff
The American Journal of Cardiology|November 11, 1998
Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularizationA M Lincoff
American Heart Journal|December 2, 2000
GUSTO IV: expanding therapeutic options in acute coronary syndromesA M Lincoff
The Journal of Invasive Cardiology|July 18, 2001
Combination therapy with reduced-dose fibrinolytic and platelet GP IIb/IIIa receptor inhibitors: SPEEDing into GUSTO VA M Lincoff
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Clinical experience with abciximab during coronary revascularisation: an overviewV Guetta, A M Lincoff
Journal of the American College of Cardiology|May 1, 1993
Trickle down thrombolysisA M Lincoff, E J Topol
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Circulation|October 7, 1997
Does stenting prevent diabetic arterial shrinkage after percutaneous coronary revascularization?A M Lincoff
American Heart Journal|January 29, 2000
Potent complementary clinical benefit of abciximab and stenting during percutaneous coronary revascularization in patients with diabetes mellitus: results of the EPISTENT trialA M Lincoff
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 18, 2001
Anticoagulant and antiplatelet drugsA M Lincoff
The Journal of Invasive Cardiology|December 9, 1993
Patients at high risk for ischemic complicationsA M Lincoff
JAMA|October 12, 2000
Stent scrutinyA M Lincoff
The American Journal of Cardiology|November 11, 1998
Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularizationA M Lincoff
American Heart Journal|December 2, 2000
GUSTO IV: expanding therapeutic options in acute coronary syndromesA M Lincoff
The Journal of Invasive Cardiology|July 18, 2001
Combination therapy with reduced-dose fibrinolytic and platelet GP IIb/IIIa receptor inhibitors: SPEEDing into GUSTO VA M Lincoff
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
Clinical experience with abciximab during coronary revascularisation: an overviewV Guetta, A M Lincoff
Journal of the American College of Cardiology|May 1, 1993
Trickle down thrombolysisA M Lincoff, E J Topol
Pageof 12